- Home
- Publications
- Publication Search
- Publication Details
Title
Oritavancin: A Long-Half-Life Lipoglycopeptide
Authors
Keywords
-
Journal
CLINICAL INFECTIOUS DISEASES
Volume 61, Issue 4, Pages 627-632
Publisher
Oxford University Press (OUP)
Online
2015-04-23
DOI
10.1093/cid/civ311
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Baseline Activity of Telavancin against Gram-Positive Clinical Isolates Responsible for Documented Infections in U.S. Hospitals (2011-2012) as Determined by the Revised Susceptibility Testing Method
- (2014) Rodrigo E. Mendes et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Single-Dose Oritavancin Versus 7–10 Days of Vancomycin in the Treatment of Gram-Positive Acute Bacterial Skin and Skin Structure Infections: The SOLO II Noninferiority Study
- (2014) G. Ralph Corey et al. CLINICAL INFECTIOUS DISEASES
- Drugs for MRSA Skin and Soft-Tissue Infections
- (2014) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Single-Dose Oritavancin in the Treatment of Acute Bacterial Skin Infections
- (2014) G. Ralph Corey et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacodynamics of a Simulated Single 1,200-Milligram Dose of Oritavancin in anIn VitroPharmacokinetic/Pharmacodynamic Model of Methicillin-Resistant Staphylococcus aureus Infection
- (2012) Adam Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Workshop on Issues in the Design of Clinical Trials for Antibacterial Drugs for Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
- (2012) John G. Bartlett et al. CLINICAL INFECTIOUS DISEASES
- Oritavancin: A New Opportunity for Outpatient Therapy of Serious Infections
- (2012) A. Tice CLINICAL INFECTIOUS DISEASES
- In Vitro Susceptibilities and Molecular Analysis of Vancomycin-Intermediate and Vancomycin-Resistant Staphylococcus aureus Isolates
- (2012) L. D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- Macrophage Killing of Bacterial and Fungal Pathogens Is Not Inhibited by Intense Intracellular Accumulation of the Lipoglycopeptide Antibiotic Oritavancin
- (2012) Beverlie Baquir et al. CLINICAL INFECTIOUS DISEASES
- In Vivo Activity of Oritavancin in Animal Infection Models and Rationale for a New Dosing Regimen in Humans
- (2012) P. G. Ambrose et al. CLINICAL INFECTIOUS DISEASES
- Oritavancin: Mechanism of Action
- (2012) George G. Zhanel et al. CLINICAL INFECTIOUS DISEASES
- Oritavancin Microbiologic Features and Activity Results From the Surveillance Program in the United States
- (2012) Rodrigo E. Mendes et al. CLINICAL INFECTIOUS DISEASES
- Practical Considerations in the Use of Outpatient Antimicrobial Therapy for Musculoskeletal Infections
- (2012) Camelia E. Marculescu et al. MAYO CLINIC PROCEEDINGS
- Comparison of the Efficacy and Safety of Oritavancin Front-Loaded Dosing Regimens to Daily Dosing: an Analysis of the SIMPLIFI Trial
- (2011) Lala M. Dunbar et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Comparison of Staphylococcus aureus From Skin and Soft-Tissue Infections in US Emergency Department Patients, 2004 and 2008
- (2011) D. A. Talan et al. CLINICAL INFECTIOUS DISEASES
- Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary
- (2011) Catherine Liu et al. CLINICAL INFECTIOUS DISEASES
- Oritavancin Disrupts Membrane Integrity of Staphylococcus aureus and Vancomycin-Resistant Enterococci To Effect Rapid Bacterial Killing
- (2010) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia
- (2009) C. M. Rubino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective
- (2009) A. L. N. Chapman et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Comparative Review of the Lipoglycopeptides: Oritavancin, Dalbavancin, and Telavancin
- (2009) Michael T Guskey et al. PHARMACOTHERAPY
- Assessment by Time-Kill Methodology of the Synergistic Effects of Oritavancin in Combination with Other Antimicrobial Agents against Staphylococcus aureus
- (2008) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Oritavancin Kills Stationary-Phase and Biofilm Staphylococcus aureus Cells In Vitro
- (2008) A. Belley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Trends in Antibacterial Use in US Academic Health Centers
- (2008) Amy L. Pakyz et al. ARCHIVES OF INTERNAL MEDICINE
- Dalbavancin: a Novel Once-Weekly Lipoglycopeptide Antibiotic
- (2008) L. D. Saravolatz et al. CLINICAL INFECTIOUS DISEASES
- Comparison of oritavancin versus vancomycin as treatments for clindamycin-induced Clostridium difficile PCR ribotype 027 infection in a human gut model
- (2008) S. D. Baines et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started